1. Inicio
  2. Proyectos y Estudios
  3. A randomized, double-blind, placebo-controlled, parallel group, Phase 3 study, followed by open-label extensions, to evaluate the efficacy of oral belumosudil in adult participants with chronic lung allograft dysfunction (CLAD) following bilateral lung transplantation.

A randomized, double-blind, placebo-controlled, parallel group, Phase 3 study, followed by open-label extensions, to evaluate the efficacy of oral belumosudil in adult participants with chronic lung allograft dysfunction (CLAD) following bilateral lung transplantation.

Datos básicos

ENSAYO CLÍNICO EFC17801 2023-503462-23 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2023

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

SANOFI AVENTIS S.A

Cita

Compartir